1. Academic Validation
  2. The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase

The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase

  • EMBO J. 2002 Jun 3;21(11):2682-91. doi: 10.1093/emboj/21.11.2682.
Olivier Kirsh 1 Jacob-S Seeler Andrea Pichler Andreas Gast Stefan Müller Eric Miska Marion Mathieu Annick Harel-Bellan Tony Kouzarides Frauke Melchior Anne Dejean
Affiliations

Affiliation

  • 1 Unité de Recombinaison et Expression Génétique, INSERM U 163, Institut Pasteur, 28 rue du Dr Roux, F-75724 Paris Cedex 15, France.
Abstract

Transcriptional repression mediated through histone deacetylation is a critical component of eukaryotic gene regulation. Here we demonstrate that the class II histone deacetylase HDAC4 is covalently modified by the ubiquitin-related SUMO-1 modifier. A sumoylation-deficient point mutant (HDAC4-K559R) shows a slightly impaired ability to repress transcription as well as reduced histone deacetylase activity. The ability of HDAC4 to self-aggregate is a prerequisite for proper sumoylation in vivo. Calcium/calmodulin-dependent protein kinase (CaMK) signalling, which induces nuclear export, abrogates SUMO-1 modification of HDAC4. Moreover, the modification depends on the presence of an intact nuclear localization signal and is catalysed by the nuclear pore complex (NPC) RanBP2 protein, a factor newly identified as a SUMO E3 Ligase. These findings suggest that sumoylation of HDAC4 takes place at the NPC and is coupled to its nuclear import. Finally, modification experiments indicate that the MEF2-interacting transcription repressor (MITR) as well as HDAC1 and -6 are similarly SUMO modified, indicating that sumoylation may be an important regulatory mechanism for the control of transcriptional repression mediated by both class I and II HDACs.

Figures